RIMONDI, Erika

RIMONDI, Erika  

Dipartimento di Scienze della Vita  

Settore BIO/16 - Anatomia Umana  

Mostra records
Risultati 1 - 20 di 30 (tempo di esecuzione: 0.036 secondi).
Titolo Data di pubblicazione Autori File
Activation of PKC-e counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members. 1-gen-2009 RIMONDI, ErikaGRILL, VITTORIO +
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members. 1-gen-2009 RIMONDI, ErikaGRILL, VITTORIOCELEGHINI, CLAUDIO +
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 1-gen-2008 RIMONDI, ErikaRUSTIGHI, ALESSANDRADEL SAL, GIANNINO +
The anti-leukemic activity of sodium dichloroacetate in p53mutated/null cells is mediated by a p53-independent ILF3/p21 pathway 1-gen-2015 RIMONDI, Erika +
C-Reactive protein downregulates TRAIL expression in human peripheral monocytes via an Egr-1-dependent pathway. 1-gen-2013 RIMONDI, Erika +
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL). 1-gen-2010 RIMONDI, ErikaCELEGHINI, CLAUDIO +
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells. 1-gen-2008 RIMONDI, ErikaGRILL, VITTORIOCELEGHINI, CLAUDIO +
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 1-gen-2011 CELEGHINI, CLAUDIORIMONDI, Erika +
GM-CSF exhibits anti-inflammatory activity on endothelial cells derived from chronic venous disease patients. 1-gen-2013 RIMONDI, Erika +
Human colostrum and breast milk contain high levels of TNF-related apoptosis-inducing ligand (TRAIL). 1-gen-2013 RIMONDI, Erika +
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells. 1-gen-2012 RIMONDI, ErikaCELEGHINI, CLAUDIO +
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 1-gen-2016 RIMONDI, ErikaCELEGHINI, CLAUDIO +
Inhibitory effect of natural anti-inflammatory compounds on cytokines released by chronic venous disease patient-derived endothelial cells. 1-gen-2013 RIMONDI, Erika +
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 1-gen-2015 RIMONDI, Erika +
Levels of TNF-related apoptosis-inducing ligand (TRAIL) show a long-term stability in the breast milk of mothers of preterm infants. 1-gen-2013 RIMONDI, Erika +
MDM2 antagonist nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts via a p53-dependent pathway. 1-gen-2007 RIMONDI, ErikaCORALLINI, FEDERICA +
Mevalonate kinase deficiency and squalene synthase inhibitor (TAK-475): The balance to extinguish the inflammation 1-gen-2021 Rimondi E.Valencic E.Tommasini A.Marcuzzi A. +
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 1-gen-2022 Marcuzzi, AnnalisaRimondi, ErikaGonelli, AriannaBarbi, Egidio +
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 1-gen-2011 CELEGHINI, CLAUDIORIMONDI, Erika +
Receptor activator of nuclear factor kappa B ligand(RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts. 1-gen-2007 RIMONDI, ErikaZWEYER, MARINA +